Genmab — Maj 2020
-
USD 11.8 billion
Report Overview. The global hemophilia market size was valued at USD 11.8 billion in 2019 and is expected to witness a CAGR of 5.5% over the forecast period. Increasing R&D initiatives especially on identifying therapeutic agents is one the major factors expected to positively impact market growth
-
Hemophilia Market Size, Growth Analysis & Industry Trends, 2031
The Hemophilia Market worth USD 15.35 billion in 2026 is growing at a CAGR of 5.4% to reach USD 19.97 billion by 2031. BioMarin Pharmaceutical Inc., CSL Ltd., F. Hoffmann-La Roche AG, Novo Nordisk A/S and Pfizer Inc. are the major companies operating in this market.
Mordor Intelligence (www.mordorintelligence.com)
-
January: The first healthy subject was dosed in the Phase I/II study of Mim8
-
Så er alle mine bull´s sluppet løs...hold da magle et cash in..:-D
-
Sønnen siger det samme.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind